TrialVaccine2013

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.

Janet A Englund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.